苯巴比妥对酶的诱导作用及人体中维生素K1的代谢处置
Enzyme induction by phenobarbitone and vitamin K1 disposition in man.
作者信息
Park B K, Wilson A C, Kaatz G, Ohnhaus E E
出版信息
Br J Clin Pharmacol. 1984 Jul;18(1):94-7. doi: 10.1111/j.1365-2125.1984.tb05028.x.
Abstract
The plasma disposition of an intravenous pharmacological dose of vitamin K1 was determined in seven healthy volunteers before and after chronic administration of phenobarbitone (100 mg nocte). Phenobarbitone produced a significant increase in antipyrine clearance and 6 beta-hydroxycortisol excretion in all volunteers, indicating induction of hepatic microsomal mixed-function oxidase enzymes. However, phenobarbitone administration had no effect on the plasma disposition of vitamin K1. We conclude therefore, that vitamin K1 is not metabolized to any significant extent, by phenobarbitone-inducible mixed-function oxidase enzymes.
摘要
在七名健康志愿者中，测定了长期服用苯巴比妥（每晚100毫克）前后静脉注射药理剂量维生素K1后的血浆处置情况。苯巴比妥使所有志愿者的安替比林清除率和6β-羟基皮质醇排泄量显著增加，表明肝微粒体混合功能氧化酶被诱导。然而，服用苯巴比妥对维生素K1的血浆处置没有影响。因此，我们得出结论，维生素K1在很大程度上不会被苯巴比妥诱导的混合功能氧化酶代谢。
相似文献
1
Enzyme induction by phenobarbitone and vitamin K1 disposition in man.苯巴比妥对酶的诱导作用及人体中维生素K1的代谢处置
Br J Clin Pharmacol. 1984 Jul;18(1):94-7. doi: 10.1111/j.1365-2125.1984.tb05028.x.
2
The effect of low-dose phenobarbitone on three indices of hepatic microsomal enzyme induction.低剂量苯巴比妥对肝微粒体酶诱导三个指标的影响
Br J Clin Pharmacol. 1986 Dec;22(6):744-7. doi: 10.1111/j.1365-2125.1986.tb02970.x.
3
The effect of phenobarbitone pre-treatment on vitamin K1 disposition in the rat and rabbit.
Biochem Pharmacol. 1984 Jan 1;33(1):141-6. doi: 10.1016/0006-2952(84)90381-2.
4
The effects of phenobarbitone on urinary 6 beta-hydroxycortisol excretion and hepatic enzyme activity in the marmoset monkey (Callithrix jacchus).苯巴比妥对狨猴（绢毛猴）尿中6β-羟基皮质醇排泄及肝酶活性的影响
Biochem Pharmacol. 1980 Dec;29(24):3319-24. doi: 10.1016/0006-2952(80)90310-x.
5
Enzyme-inducing drug combinations and their effects on liver microsomal enzyme activity in man.酶诱导药物组合及其对人体肝脏微粒体酶活性的影响。
Eur J Clin Pharmacol. 1983;24(2):247-50. doi: 10.1007/BF00613826.
6
Urinary excretion of 6 beta-hydroxycortisol and the time course measurement of enzyme induction in man.人体中6β-羟基皮质醇的尿排泄及酶诱导的时间进程测量
Eur J Clin Pharmacol. 1989;36(1):39-46. doi: 10.1007/BF00561021.
7
Measurement of urinary 6-beta-hydroxycortisol excretion as an in vivo parameter in the clinical assessment of the microsomal enzyme-inducing capacity of antipyrine, phenobarbitone and rifampicin.测定尿中6-β-羟基皮质醇排泄量作为体内参数，用于临床评估安替比林、苯巴比妥和利福平的微粒体酶诱导能力。
Eur J Clin Pharmacol. 1979 Mar 26;15(2):139-45. doi: 10.1007/BF00609878.
8
Enzyme induction and renal function in man.人体中的酶诱导作用与肾功能
Br J Clin Pharmacol. 1977 Feb;4(1):33-7. doi: 10.1111/j.1365-2125.1977.tb00663.x.
9
The effects of phenobarbitone on urinary 6 beta-hydroxycortisol excretion and hepatic enzyme activity in the guinea-pig.
J Steroid Biochem. 1983 Apr;18(4):453-7. doi: 10.1016/0022-4731(83)90065-1.
10
Induction of microsomal drug metabolizing enzymes by phenobarbitone in the rats exposed to increased environmental temperature.
Acta Pol Pharm. 1991;48(3-4):35-7.
引用本文的文献
1
Should Cytochrome P450 Inducers be Used to Accelerate Clearance of Brodifacoum from Poisoned Patients?细胞色素 P450 诱导剂是否可用于加速中毒患者体内溴鼠灵的清除？
Drugs R D. 2019 Mar;19(1):67-71. doi: 10.1007/s40268-019-0261-4.
2
Urinary 6beta-hydroxycortisol: a validated test for evaluating drug induction or drug inhibition mediated through CYP3A in humans and in animals.尿6β-羟基皮质醇：一种用于评估人类和动物中通过CYP3A介导的药物诱导或药物抑制作用的有效检测方法。
Eur J Clin Pharmacol. 2003 Dec;59(10):713-33. doi: 10.1007/s00228-003-0690-3. Epub 2003 Nov 6.
3
Hepatic enzyme induction and vitamin K1 elimination in man.人体中的肝酶诱导作用与维生素K1消除
Eur J Clin Pharmacol. 1987;33(1):93-5. doi: 10.1007/BF00610388.
4
Effect of the removal of individual antiepileptic drugs on antipyrine kinetics, in patients taking polytherapy.在接受联合治疗的患者中，去除个别抗癫痫药物对安替比林动力学的影响。
Br J Clin Pharmacol. 1988 Sep;26(3):253-9. doi: 10.1111/j.1365-2125.1988.tb05274.x.
本文引用的文献
1
A pharmacokinetic program for TI-59.TI - 59的药代动力学程序。
J Pharmacol Methods. 1980 Jun;3(4):345-55. doi: 10.1016/0160-5402(80)90076-5.
2
Rifampicin and vitamin D metabolism.利福平与维生素D代谢
Clin Pharmacol Ther. 1980 Jun;27(6):810-4. doi: 10.1038/clpt.1980.115.
3
Preparative isolation and characterization of the urinary aglycones of vitamin K1 (phylloquinone in man.
Biochem Med. 1980 Dec;24(3):250-67. doi: 10.1016/0006-2944(80)90020-4.
4
Recent findings in understanding the biological function of vitamin K.近期在理解维生素K生物学功能方面的研究发现。
Med Biol. 1982 Feb;60(1):16-24.
5
The effect of phenobarbitone pre-treatment on vitamin K1 disposition in the rat and rabbit.
Biochem Pharmacol. 1984 Jan 1;33(1):141-6. doi: 10.1016/0006-2952(84)90381-2.
6
Quantitative analysis of pharmacological levels of vitamin K1 and vitamin K1 2,3-epoxide in rabbit plasma by high-performance liquid chromatography.高效液相色谱法对兔血浆中维生素K1及维生素K1 2,3-环氧化物药理水平的定量分析
J Chromatogr. 1983 Oct 14;277:292-9. doi: 10.1016/s0378-4347(00)84847-1.
7
Transplacental vitamin K prevents haemorrhagic disease of infant of epileptic mother.经胎盘给予维生素K可预防癫痫母亲所生婴儿的出血性疾病。
Lancet. 1982 May 29;1(8283):1247. doi: 10.1016/s0140-6736(82)92371-6.
8
Neonatal haemorrhage associated with maternal anticonvulsant therapy.与母亲抗惊厥治疗相关的新生儿出血。
Lancet. 1981 Dec 5;2(8258):1296-7. doi: 10.1016/s0140-6736(81)91542-7.
9
Clinical implications of enzyme induction and enzyme inhibition.酶诱导和酶抑制的临床意义。
Clin Pharmacokinet. 1981 Jan-Feb;6(1):1-24. doi: 10.2165/00003088-198106010-00001.
10
Clearance from plasma and excretion in urine, faeces and bile of an intravenous dose of tritiated vitamin K 1 in man.静脉注射剂量的氚标记维生素K1在人体血浆中的清除率以及在尿液、粪便和胆汁中的排泄情况。
Br J Haematol. 1972 May;22(5):579-88. doi: 10.1111/j.1365-2141.1972.tb05704.x.
Zotero 插件